Table 7.

Medical outcome themes and individual observations commensurate with adoption of the intervention/technology (N=30).

Themes/observations	References	Occurrence, n (%)
Improved in at least one area	[27,32,35,40,46,48,53-55,58,59,67]	12 (40)
No statistically significant difference	[30,33,45]	3 (10)
Decreased body weight	[32,35,58]	3 (10)
Decreased fat mass	[27,35]	2 (7)
Improved self-management	[43,67]	2 (7)
Increase in controlled asthma	[43,60]	2 (7)
Improved quality of life	[55,59]	2 (7)
Reductions in blood pressure	[40]	1 (3)
Reduction in mean tacrolimus trough coefficient of variation	[54]	1 (3)
Improved annual rate of eGFRa decline	[48]	1 (3)
Decreased medication use	[43]	1 (3)
Decreased incidence of heart failure	[46]	1 (3)
Identified other areas for intervention	[50]	1 (3)
Decreased mortality	[53]	1 (3)
Improved mental health inventory	[55]	1 (3)
Decreased intracranial hemorrhage	[53]	1 (3)
Not reported	[22-26,28,29,31,34,36-39,41,42,44,47,49,51,52,56,57,61-66]	28 (N/Ab)

^aeGFR: estimated glomerular filtration rate.

^bN/A: not applicable.